{"name":"InteRNA","slug":"interna","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":310614,"revenueGrowth":109.7,"grossMargin":0,"rdSpend":0,"netIncome":-3451195,"cash":1785209,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2011"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":46,"colorKey":"oncology","drugs":[{"name":"Quadrivalent Influenza Vaccine","genericName":"Quadrivalent Influenza Vaccine","slug":"quadrivalent-influenza-vaccine","indication":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in people 6 months of age and older","status":"marketed"},{"name":"Bivalent OPV 2 week interval","genericName":"Bivalent OPV 2 week interval","slug":"bivalent-opv-2-week-interval","indication":"Poliomyelitis prevention (poliovirus types 1 and 3)","status":"marketed"},{"name":"Dabigatran Etexilate Capsules 150 mg","genericName":"Dabigatran Etexilate Capsules 150 mg","slug":"dabigatran-etexilate-capsules-150-mg","indication":"Other","status":"phase_1"},{"name":"Dukoral®","genericName":"Dukoral®","slug":"dukoral","indication":"Other","status":"marketed"},{"name":"Experimental: Active \"I-Reconstruction\" Therapy","genericName":"Experimental: Active \"I-Reconstruction\" Therapy","slug":"experimental-active-i-reconstruction-therapy","indication":"Other","status":"marketed"},{"name":"JE vaccine new plant lot 3","genericName":"JE vaccine new plant lot 3","slug":"je-vaccine-new-plant-lot-3","indication":"Other","status":"marketed"},{"name":"Rotavirus Vaccine (ROTARIX)","genericName":"Rotavirus Vaccine (ROTARIX)","slug":"rotavirus-vaccine-rotarix","indication":"Prevention of rotavirus gastroenteritis in infants and young children","status":"marketed"},{"name":"TBC-M4","genericName":"TBC-M4","slug":"tbc-m4","indication":"Other","status":"phase_1"},{"name":"Trivalent OPV 4 week interval","genericName":"Trivalent OPV 4 week interval","slug":"trivalent-opv-4-week-interval","indication":"Poliomyelitis prevention (poliovirus types 1, 2, and 3)","status":"marketed"},{"name":"Vi-DT (Multi-dose formulation)","genericName":"Vi-DT (Multi-dose formulation)","slug":"vi-dt-multi-dose-formulation","indication":"Prevention of typhoid fever","status":"phase_3"},{"name":"Whole cell killed cholera vaccine & probiotic","genericName":"Whole cell killed cholera vaccine & probiotic","slug":"whole-cell-killed-cholera-vaccine-probiotic","indication":"Other","status":"phase_1"},{"name":"mRNA-1645-eODGT8","genericName":"mRNA-1645-eODGT8","slug":"mrna-1645-eodgt8","indication":"Other","status":"phase_1"},{"name":"Active Comparator, Euvichol®-Plus","genericName":"Active Comparator, Euvichol®-Plus","slug":"active-comparator-euvichol-plus","indication":"Prevention of cholera caused by Vibrio cholerae O1 and O139 in endemic and epidemic regions","status":"phase_3"},{"name":"Amylase resistant starch added ORS","genericName":"Amylase resistant starch added ORS","slug":"amylase-resistant-starch-added-ors","indication":"Acute diarrhea (cholera and non-cholera)","status":"phase_3"},{"name":"BG505 SOSIP GT1.1 gp140 Vaccine, Adjuvanted","genericName":"BG505 SOSIP GT1.1 gp140 Vaccine, Adjuvanted","slug":"bg505-sosip-gt1-1-gp140-vaccine-adjuvanted","indication":"Other","status":"phase_1"},{"name":"Bivalent OPV 4 week interval","genericName":"Bivalent OPV 4 week interval","slug":"bivalent-opv-4-week-interval","indication":"Other","status":"marketed"},{"name":"Blood and Dopamine","genericName":"Blood and Dopamine","slug":"blood-and-dopamine","indication":"Other","status":"phase_3"},{"name":"Cholvax","genericName":"Cholvax","slug":"cholvax","indication":"Other","status":"phase_2"},{"name":"Control Vaccine Typbar TCV®","genericName":"Control Vaccine Typbar TCV®","slug":"control-vaccine-typbar-tcv","indication":"Prevention of typhoid fever caused by Salmonella typhi","status":"phase_3"},{"name":"DS003 vaginal tablet","genericName":"DS003 vaginal tablet","slug":"ds003-vaginal-tablet","indication":"Other","status":"phase_1"},{"name":"Dapivirine Vaginal Film","genericName":"Dapivirine Vaginal Film","slug":"dapivirine-vaginal-film","indication":"Other","status":"phase_1"},{"name":"Fractional IPV( fIPV)","genericName":"Fractional IPV( fIPV)","slug":"fractional-ipv-fipv","indication":"Poliomyelitis prevention in infants and children","status":"marketed"},{"name":"Hypo-osmolar ORS","genericName":"Hypo-osmolar ORS","slug":"hypo-osmolar-ors","indication":"Other","status":"marketed"},{"name":"JE Vaccine existing facility","genericName":"JE Vaccine existing facility","slug":"je-vaccine-existing-facility","indication":"Prevention of Japanese encephalitis in endemic regions","status":"marketed"},{"name":"JE vaccine new plant lot 1","genericName":"JE vaccine new plant lot 1","slug":"je-vaccine-new-plant-lot-1","indication":"Prevention of Japanese encephalitis in endemic regions","status":"marketed"},{"name":"JE vaccine new plant lot 2","genericName":"JE vaccine new plant lot 2","slug":"je-vaccine-new-plant-lot-2","indication":"Prevention of Japanese encephalitis in endemic regions","status":"marketed"},{"name":"LC16m8","genericName":"LC16m8","slug":"lc16m8","indication":"Smallpox prevention","status":"phase_3"},{"name":"MCV-A vaccine","genericName":"MCV-A vaccine","slug":"mcv-a-vaccine","indication":"Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup A","status":"marketed"},{"name":"Measles and Rubella (MR)","genericName":"Measles and Rubella (MR)","slug":"measles-and-rubella-mr","indication":"Prevention of measles","status":"phase_3"},{"name":"Measles and rubella Vaccine","genericName":"Measles and rubella Vaccine","slug":"measles-and-rubella-vaccine","indication":"Other","status":"marketed"},{"name":"Meningococcal A (control)","genericName":"Meningococcal A (control)","slug":"meningococcal-a-control","indication":"Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup A","status":"marketed"},{"name":"Mitefosine","genericName":"Mitefosine","slug":"mitefosine","indication":"Other","status":"marketed"},{"name":"Monovalent OPV 2 week interval","genericName":"Monovalent OPV 2 week interval","slug":"monovalent-opv-2-week-interval","indication":"Other","status":"marketed"},{"name":"Monovalent OPV 4 week interval","genericName":"Monovalent OPV 4 week interval","slug":"monovalent-opv-4-week-interval","indication":"Other","status":"marketed"},{"name":"Oral Cholera Vaccine (OCV)","genericName":"Oral Cholera Vaccine (OCV)","slug":"oral-cholera-vaccine-ocv","indication":"Prevention of cholera in individuals traveling to or living in areas where cholera is common","status":"phase_3"},{"name":"Pentavalent vaccine","genericName":"Pentavalent vaccine","slug":"pentavalent-vaccine","indication":"Other","status":"marketed"},{"name":"Rotavirus Vaccine & Breastfeeding","genericName":"Rotavirus Vaccine & Breastfeeding","slug":"rotavirus-vaccine-breastfeeding","indication":"Prevention of severe rotavirus gastroenteritis in infants and young children","status":"phase_3"},{"name":"Shanchol vaccine","genericName":"Shanchol vaccine","slug":"shanchol-vaccine","indication":"Prevention of cholera caused by Vibrio cholerae O1 and O139 in endemic and epidemic settings","status":"phase_3"},{"name":"Synera patch twice daily","genericName":"Synera patch twice daily","slug":"synera-patch-twice-daily","indication":"Other","status":"marketed"},{"name":"Test Vaccine Vi-DT Typhoid conjugate","genericName":"Test Vaccine Vi-DT Typhoid conjugate","slug":"test-vaccine-vi-dt-typhoid-conjugate","indication":"Prevention of typhoid fever","status":"phase_3"},{"name":"Typhoid Vi vaccine","genericName":"Typhoid Vi vaccine","slug":"typhoid-vi-vaccine","indication":"Prevention of typhoid fever caused by Salmonella typhi in travelers and at-risk populations","status":"marketed"},{"name":"Vi-TT","genericName":"Vi-TT","slug":"vi-tt","indication":"Prevention of typhoid fever caused by Salmonella typhi","status":"marketed"},{"name":"combined fixed dose combination","genericName":"combined fixed dose combination","slug":"combined-fixed-dose-combination","indication":"Other","status":"marketed"},{"name":"emtricitabine, tenofovir, ritonavir, atazanavir","genericName":"emtricitabine, tenofovir, ritonavir, atazanavir","slug":"emtricitabine-tenofovir-ritonavir-atazanavir","indication":"Other","status":"marketed"},{"name":"lamivudine, abacavir , ritonavir, atazanavir","genericName":"lamivudine, abacavir , ritonavir, atazanavir","slug":"lamivudine-abacavir-ritonavir-atazanavir","indication":"Other","status":"marketed"},{"name":"polio vaccines: nOPV2, bOPV, IPV","genericName":"polio vaccines: nOPV2, bOPV, IPV","slug":"polio-vaccines-nopv2-bopv-ipv","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"immunology","drugs":[{"name":"Hepatitis A (control)","genericName":"Hepatitis A (control)","slug":"hepatitis-a-control","indication":"Prevention of hepatitis A virus infection in susceptible populations","status":"marketed"},{"name":"MTBVAC","genericName":"MTBVAC","slug":"mtbvac","indication":"Tuberculosis prevention in adolescents and adults (Phase 3)","status":"phase_3"},{"name":"ZDV+3TC+LPV/r","genericName":"ZDV+3TC+LPV/r","slug":"zdv-3tc-lpv-r","indication":"HIV-1 infection in pediatric and adolescent patients","status":"marketed"},{"name":"Dapivirine Vaginal Ring-004","genericName":"Dapivirine Vaginal Ring-004","slug":"dapivirine-vaginal-ring-004","indication":"HIV-1 prevention in women (pre-exposure prophylaxis)","status":"phase_3"},{"name":"HAV vaccine","genericName":"HAV vaccine","slug":"hav-vaccine","indication":"Prevention of hepatitis A infection in susceptible populations","status":"phase_3"},{"name":"Hepa-B","genericName":"Hepa-B","slug":"hepa-b","indication":"Prevention of hepatitis B virus infection in infants, children, and adults","status":"marketed"},{"name":"Hexavalent vaccine","genericName":"Hexavalent vaccine","slug":"hexavalent-vaccine","indication":"Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b infection in infants and children","status":"marketed"},{"name":"Pneumococcal protein vaccine","genericName":"Pneumococcal protein vaccine","slug":"pneumococcal-protein-vaccine","indication":"Prevention of pneumococcal disease (pneumonia, bacteremia, meningitis)","status":"marketed"},{"name":"Test Oral Cholera Vaccine","genericName":"Test Oral Cholera Vaccine","slug":"test-oral-cholera-vaccine","indication":"Prevention of cholera infection","status":"phase_3"},{"name":"saquinavir/ritonavir","genericName":"saquinavir/ritonavir","slug":"saquinavir-ritonavir","indication":"HIV-1 infection in treatment-experienced patients","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"high dose cytarabine","genericName":"high dose cytarabine","slug":"high-dose-cytarabine","indication":"Acute myeloid leukemia (AML)","status":"phase_3"},{"name":"chlorambucil (drug)","genericName":"chlorambucil (drug)","slug":"chlorambucil-drug","indication":"Chronic lymphocytic leukemia (CLL)","status":"phase_3"},{"name":"quadrivalent HPV vaccine","genericName":"quadrivalent HPV vaccine","slug":"quadrivalent-hpv-vaccine","indication":"Prevention of cervical cancer caused by HPV types 16 and 18","status":"marketed"},{"name":"rituximab+chlorambucil","genericName":"rituximab+chlorambucil","slug":"rituximab-chlorambucil","indication":"Follicular lymphoma","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"Benzathine penicillin G","genericName":"Benzathine penicillin G","slug":"benzathine-penicillin-g","indication":"Streptococcal pharyngitis and tonsillitis","status":"marketed"},{"name":"Oral Polio Vaccine","genericName":"Oral Polio Vaccine","slug":"oral-polio-vaccine","indication":"Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Blood and adrenaline","genericName":"Blood and adrenaline","slug":"blood-and-adrenaline","indication":"Cardiogenic shock","status":"phase_3"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Synera patch for 12hrs/day","genericName":"Synera patch for 12hrs/day","slug":"synera-patch-for-12hrs-day","indication":"Topical anesthesia for minor procedures (e.g., venipuncture, dermatological procedures)","status":"marketed"}]}],"pipeline":[{"name":"Quadrivalent Influenza Vaccine","genericName":"Quadrivalent Influenza Vaccine","slug":"quadrivalent-influenza-vaccine","phase":"marketed","mechanism":"This vaccine works by stimulating the body's immune system to produce antibodies against influenza viruses.","indications":["Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in people 6 months of age and older","Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in people 6 months of age and older, when the circulating influenza A and B viruses are expected to be well matched to the vaccine viruses."],"catalyst":""},{"name":"Bivalent OPV 2 week interval","genericName":"Bivalent OPV 2 week interval","slug":"bivalent-opv-2-week-interval","phase":"marketed","mechanism":"Bivalent OPV provides immunization against poliovirus types 1 and 3 by stimulating the immune system to produce antibodies against these two serotypes.","indications":["Poliomyelitis prevention (poliovirus types 1 and 3)"],"catalyst":""},{"name":"Dabigatran Etexilate Capsules 150 mg","genericName":"Dabigatran Etexilate Capsules 150 mg","slug":"dabigatran-etexilate-capsules-150-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dukoral®","genericName":"Dukoral®","slug":"dukoral","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Experimental: Active \"I-Reconstruction\" Therapy","genericName":"Experimental: Active \"I-Reconstruction\" Therapy","slug":"experimental-active-i-reconstruction-therapy","phase":"marketed","mechanism":"Ofloxacin ophthalmic solution is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, leading to bacterial cell death.","indications":[],"catalyst":""},{"name":"Hepatitis A (control)","genericName":"Hepatitis A (control)","slug":"hepatitis-a-control","phase":"marketed","mechanism":"This inactivated hepatitis A vaccine stimulates the immune system to produce antibodies against hepatitis A virus, providing protective immunity against infection.","indications":["Prevention of hepatitis A virus infection in susceptible populations"],"catalyst":""},{"name":"JE vaccine new plant lot 3","genericName":"JE vaccine new plant lot 3","slug":"je-vaccine-new-plant-lot-3","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"MTBVAC","genericName":"MTBVAC","slug":"mtbvac","phase":"phase_3","mechanism":"MTBVAC is a live attenuated tuberculosis vaccine that stimulates immune responses against Mycobacterium tuberculosis to prevent active TB disease.","indications":["Tuberculosis prevention in adolescents and adults (Phase 3)"],"catalyst":""},{"name":"Rotavirus Vaccine (ROTARIX)","genericName":"Rotavirus Vaccine (ROTARIX)","slug":"rotavirus-vaccine-rotarix","phase":"marketed","mechanism":"ROTARIX is a live attenuated rotavirus vaccine that stimulates the immune system to produce antibodies and cellular immunity against rotavirus infection.","indications":["Prevention of rotavirus gastroenteritis in infants and young children"],"catalyst":""},{"name":"TBC-M4","genericName":"TBC-M4","slug":"tbc-m4","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Trivalent OPV 4 week interval","genericName":"Trivalent OPV 4 week interval","slug":"trivalent-opv-4-week-interval","phase":"marketed","mechanism":"Trivalent OPV provides immunization against three serotypes of poliovirus (types 1, 2, and 3) by inducing mucosal and systemic immune responses through oral administration of live attenuated virus.","indications":["Poliomyelitis prevention (poliovirus types 1, 2, and 3)"],"catalyst":""},{"name":"Vi-DT (Multi-dose formulation)","genericName":"Vi-DT (Multi-dose formulation)","slug":"vi-dt-multi-dose-formulation","phase":"phase_3","mechanism":"Vi-DT is a vaccine that stimulates the immune system to produce antibodies against a specific target.","indications":["Prevention of typhoid fever"],"catalyst":""},{"name":"Whole cell killed cholera vaccine & probiotic","genericName":"Whole cell killed cholera vaccine & probiotic","slug":"whole-cell-killed-cholera-vaccine-probiotic","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ZDV+3TC+LPV/r","genericName":"ZDV+3TC+LPV/r","slug":"zdv-3tc-lpv-r","phase":"marketed","mechanism":"This combination inhibits HIV reverse transcriptase and protease to suppress viral replication.","indications":["HIV-1 infection in pediatric and adolescent patients","Prevention of mother-to-child transmission of HIV"],"catalyst":""},{"name":"high dose cytarabine","genericName":"high dose cytarabine","slug":"high-dose-cytarabine","phase":"phase_3","mechanism":"High-dose cytarabine is a nucleoside analog that inhibits DNA synthesis by being incorporated into DNA, leading to cell death in rapidly dividing cells.","indications":["Acute myeloid leukemia (AML)","Acute lymphoblastic leukemia (ALL)","Primary CNS lymphoma","Lymphoma (as part of combination chemotherapy regimens)"],"catalyst":""},{"name":"mRNA-1645-eODGT8","genericName":"mRNA-1645-eODGT8","slug":"mrna-1645-eodgt8","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Active Comparator, Euvichol®-Plus","genericName":"Active Comparator, Euvichol®-Plus","slug":"active-comparator-euvichol-plus","phase":"phase_3","mechanism":"Euvichol-Plus is an oral cholera vaccine that stimulates immune responses against Vibrio cholerae to prevent cholera infection.","indications":["Prevention of cholera caused by Vibrio cholerae O1 and O139 in endemic and epidemic regions"],"catalyst":""},{"name":"Amylase resistant starch added ORS","genericName":"Amylase resistant starch added ORS","slug":"amylase-resistant-starch-added-ors","phase":"phase_3","mechanism":"Amylase-resistant starch in oral rehydration solution reduces stool output and improves water absorption in diarrheal disease by providing a slowly fermentable carbohydrate substrate.","indications":["Acute diarrhea (cholera and non-cholera)","Diarrheal disease in children"],"catalyst":""},{"name":"BG505 SOSIP GT1.1 gp140 Vaccine, Adjuvanted","genericName":"BG505 SOSIP GT1.1 gp140 Vaccine, Adjuvanted","slug":"bg505-sosip-gt1-1-gp140-vaccine-adjuvanted","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Benzathine penicillin G","genericName":"Benzathine penicillin G","slug":"benzathine-penicillin-g","phase":"marketed","mechanism":"Benzathine penicillin G inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking peptidoglycan cross-linking.","indications":["Streptococcal pharyngitis and tonsillitis","Acute rheumatic fever prophylaxis","Secondary prophylaxis of rheumatic heart disease","Early syphilis","Congenital syphilis"],"catalyst":""},{"name":"Bivalent OPV 4 week interval","genericName":"Bivalent OPV 4 week interval","slug":"bivalent-opv-4-week-interval","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Blood and Dopamine","genericName":"Blood and Dopamine","slug":"blood-and-dopamine","phase":"phase_3","mechanism":"Unknown mechanism; the drug name suggests potential involvement in blood regulation and dopaminergic pathways, but specific molecular action is not established.","indications":[],"catalyst":""},{"name":"Blood and adrenaline","genericName":"Blood and adrenaline","slug":"blood-and-adrenaline","phase":"phase_3","mechanism":"This drug stimulates the release of adrenaline and increases blood flow to vital organs.","indications":["Cardiogenic shock"],"catalyst":""},{"name":"Cholvax","genericName":"Cholvax","slug":"cholvax","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Control Vaccine Typbar TCV®","genericName":"Control Vaccine Typbar TCV®","slug":"control-vaccine-typbar-tcv","phase":"phase_3","mechanism":"Typbar TCV is a conjugate vaccine that stimulates immune response against Salmonella typhi by presenting purified polysaccharide antigens conjugated to a carrier protein.","indications":["Prevention of typhoid fever caused by Salmonella typhi"],"catalyst":""},{"name":"DS003 vaginal tablet","genericName":"DS003 vaginal tablet","slug":"ds003-vaginal-tablet","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dapivirine Vaginal Film","genericName":"Dapivirine Vaginal Film","slug":"dapivirine-vaginal-film","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dapivirine Vaginal Ring-004","genericName":"Dapivirine Vaginal Ring-004","slug":"dapivirine-vaginal-ring-004","phase":"phase_3","mechanism":"Dapivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that blocks HIV replication when released from a vaginal ring formulation.","indications":["HIV-1 prevention in women (pre-exposure prophylaxis)"],"catalyst":""},{"name":"Fractional IPV( fIPV)","genericName":"Fractional IPV( fIPV)","slug":"fractional-ipv-fipv","phase":"marketed","mechanism":"Fractional IPV (fIPV) is a reduced-dose inactivated polio vaccine that provides immunological protection against poliovirus while using a smaller antigen quantity per dose.","indications":["Poliomyelitis prevention in infants and children"],"catalyst":""},{"name":"HAV vaccine","genericName":"HAV vaccine","slug":"hav-vaccine","phase":"phase_3","mechanism":"HAV vaccine stimulates the immune system to produce antibodies against hepatitis A virus, providing protection against infection.","indications":["Prevention of hepatitis A infection in susceptible populations","Post-exposure prophylaxis for hepatitis A"],"catalyst":""},{"name":"Hepa-B","genericName":"Hepa-B","slug":"hepa-b","phase":"marketed","mechanism":"Hepa-B is a hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection.","indications":["Prevention of hepatitis B virus infection in infants, children, and adults"],"catalyst":""},{"name":"Hexavalent vaccine","genericName":"Hexavalent vaccine","slug":"hexavalent-vaccine","phase":"marketed","mechanism":"A hexavalent vaccine that provides immunization against six infectious diseases by stimulating the immune system to produce antibodies and cellular immunity against multiple pathogens.","indications":["Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b infection in infants and children"],"catalyst":""},{"name":"Hypo-osmolar ORS","genericName":"Hypo-osmolar ORS","slug":"hypo-osmolar-ors","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"JE Vaccine existing facility","genericName":"JE Vaccine existing facility","slug":"je-vaccine-existing-facility","phase":"marketed","mechanism":"JE Vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.","indications":["Prevention of Japanese encephalitis in endemic regions"],"catalyst":""},{"name":"JE vaccine new plant lot 1","genericName":"JE vaccine new plant lot 1","slug":"je-vaccine-new-plant-lot-1","phase":"marketed","mechanism":"JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.","indications":["Prevention of Japanese encephalitis in endemic regions"],"catalyst":""},{"name":"JE vaccine new plant lot 2","genericName":"JE vaccine new plant lot 2","slug":"je-vaccine-new-plant-lot-2","phase":"marketed","mechanism":"JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.","indications":["Prevention of Japanese encephalitis in endemic regions"],"catalyst":""},{"name":"LC16m8","genericName":"LC16m8","slug":"lc16m8","phase":"phase_3","mechanism":"LC16m8 is a live attenuated vaccinia virus vaccine designed to provide immunization against smallpox and monkeypox through viral replication and immune stimulation.","indications":["Smallpox prevention","Monkeypox prevention"],"catalyst":""},{"name":"MCV-A vaccine","genericName":"MCV-A vaccine","slug":"mcv-a-vaccine","phase":"marketed","mechanism":"MCV-A vaccine stimulates the immune system to produce antibodies and cellular immunity against meningococcal serogroup A polysaccharide capsule.","indications":["Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup A"],"catalyst":""},{"name":"Measles and Rubella (MR)","genericName":"Measles and Rubella (MR)","slug":"measles-and-rubella-mr","phase":"phase_3","mechanism":"The MR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles and rubella viruses through live attenuated viral antigens.","indications":["Prevention of measles","Prevention of rubella"],"catalyst":""},{"name":"Measles and rubella Vaccine","genericName":"Measles and rubella Vaccine","slug":"measles-and-rubella-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Meningococcal A (control)","genericName":"Meningococcal A (control)","slug":"meningococcal-a-control","phase":"marketed","mechanism":"This vaccine stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup A polysaccharide capsule.","indications":["Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup A"],"catalyst":""},{"name":"Mitefosine","genericName":"Mitefosine","slug":"mitefosine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Monovalent OPV 2 week interval","genericName":"Monovalent OPV 2 week interval","slug":"monovalent-opv-2-week-interval","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Monovalent OPV 4 week interval","genericName":"Monovalent OPV 4 week interval","slug":"monovalent-opv-4-week-interval","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Oral Cholera Vaccine (OCV)","genericName":"Oral Cholera Vaccine (OCV)","slug":"oral-cholera-vaccine-ocv","phase":"phase_3","mechanism":"The Oral Cholera Vaccine (OCV) works by stimulating the body's immune system to produce antibodies against Vibrio cholerae, the bacteria that causes cholera.","indications":["Prevention of cholera in individuals traveling to or living in areas where cholera is common"],"catalyst":""},{"name":"Oral Polio Vaccine","genericName":"Oral Polio Vaccine","slug":"oral-polio-vaccine","phase":"marketed","mechanism":"Oral Polio Vaccine stimulates the immune system to produce antibodies against poliovirus by delivering live attenuated (weakened) poliovirus strains orally.","indications":["Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3","Routine childhood immunization against polio"],"catalyst":""},{"name":"Pentavalent vaccine","genericName":"Pentavalent vaccine","slug":"pentavalent-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Pneumococcal protein vaccine","genericName":"Pneumococcal protein vaccine","slug":"pneumococcal-protein-vaccine","phase":"marketed","mechanism":"This vaccine stimulates the immune system to produce antibodies and cellular immunity against pneumococcal protein antigens, preventing infection by Streptococcus pneumoniae.","indications":["Prevention of pneumococcal disease (pneumonia, bacteremia, meningitis)"],"catalyst":""},{"name":"Rotavirus Vaccine & Breastfeeding","genericName":"Rotavirus Vaccine & Breastfeeding","slug":"rotavirus-vaccine-breastfeeding","phase":"phase_3","mechanism":"The Rotavirus Vaccine works by stimulating the body's immune system to produce antibodies against rotavirus, thereby preventing infection.","indications":["Prevention of severe rotavirus gastroenteritis in infants and young children"],"catalyst":""},{"name":"Shanchol vaccine","genericName":"Shanchol vaccine","slug":"shanchol-vaccine","phase":"phase_3","mechanism":"Shanchol is an oral, inactivated cholera vaccine that stimulates immune responses against Vibrio cholerae O1 and O139 antigens to prevent cholera infection.","indications":["Prevention of cholera caused by Vibrio cholerae O1 and O139 in endemic and epidemic settings"],"catalyst":""},{"name":"Synera patch for 12hrs/day","genericName":"Synera patch for 12hrs/day","slug":"synera-patch-for-12hrs-day","phase":"marketed","mechanism":"Synera patch delivers lidocaine and tetracaine through the skin to provide topical anesthesia by blocking sodium channels in nerve fibers.","indications":["Topical anesthesia for minor procedures (e.g., venipuncture, dermatological procedures)","Localized pain relief"],"catalyst":""},{"name":"Synera patch twice daily","genericName":"Synera patch twice daily","slug":"synera-patch-twice-daily","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Test Oral Cholera Vaccine","genericName":"Test Oral Cholera Vaccine","slug":"test-oral-cholera-vaccine","phase":"phase_3","mechanism":"This vaccine induces an immune response against Vibrio cholerae, preventing cholera infection.","indications":["Prevention of cholera infection"],"catalyst":""},{"name":"Test Vaccine Vi-DT Typhoid conjugate","genericName":"Test Vaccine Vi-DT Typhoid conjugate","slug":"test-vaccine-vi-dt-typhoid-conjugate","phase":"phase_3","mechanism":"Vi-DT Typhoid conjugate vaccine stimulates the immune system to produce antibodies against Salmonella Typhi.","indications":["Prevention of typhoid fever"],"catalyst":""},{"name":"Typhoid Vi vaccine","genericName":"Typhoid Vi vaccine","slug":"typhoid-vi-vaccine","phase":"marketed","mechanism":"The Typhoid Vi vaccine stimulates the immune system to produce antibodies and cellular immunity against Salmonella typhi by presenting the bacterial Vi polysaccharide capsular antigen.","indications":["Prevention of typhoid fever caused by Salmonella typhi in travelers and at-risk populations"],"catalyst":""},{"name":"Vi-TT","genericName":"Vi-TT","slug":"vi-tt","phase":"marketed","mechanism":"Vi-TT is a typhoid conjugate vaccine that stimulates immune responses against Salmonella typhi by presenting the polysaccharide capsule antigen conjugated to a protein carrier.","indications":["Prevention of typhoid fever caused by Salmonella typhi"],"catalyst":""},{"name":"chlorambucil (drug)","genericName":"chlorambucil (drug)","slug":"chlorambucil-drug","phase":"phase_3","mechanism":"Chlorambucil is an alkylating agent that cross-links DNA strands, preventing cell division and causing cancer cell death.","indications":["Chronic lymphocytic leukemia (CLL)","Lymphomas (Hodgkin and non-Hodgkin)","Waldenström macroglobulinemia"],"catalyst":""},{"name":"combined fixed dose combination","genericName":"combined fixed dose combination","slug":"combined-fixed-dose-combination","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"emtricitabine, tenofovir, ritonavir, atazanavir","genericName":"emtricitabine, tenofovir, ritonavir, atazanavir","slug":"emtricitabine-tenofovir-ritonavir-atazanavir","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"lamivudine, abacavir , ritonavir, atazanavir","genericName":"lamivudine, abacavir , ritonavir, atazanavir","slug":"lamivudine-abacavir-ritonavir-atazanavir","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"polio vaccines: nOPV2, bOPV, IPV","genericName":"polio vaccines: nOPV2, bOPV, IPV","slug":"polio-vaccines-nopv2-bopv-ipv","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"quadrivalent HPV vaccine","genericName":"quadrivalent HPV vaccine","slug":"quadrivalent-hpv-vaccine","phase":"marketed","mechanism":"The quadrivalent HPV vaccine stimulates the immune system to produce antibodies against four types of human papillomavirus (HPV-6, 11, 16, and 18) to prevent infection and associated cancers.","indications":["Prevention of cervical cancer caused by HPV types 16 and 18","Prevention of genital warts caused by HPV types 6 and 11","Prevention of anal, vulvar, vaginal, and oropharyngeal cancers associated with HPV types 6, 11, 16, and 18"],"catalyst":""},{"name":"rituximab+chlorambucil","genericName":"rituximab+chlorambucil","slug":"rituximab-chlorambucil","phase":"phase_3","mechanism":"Rituximab is a monoclonal antibody that targets and depletes CD20-positive B cells, while chlorambucil is an alkylating agent that interferes with DNA replication.","indications":["Follicular lymphoma","Mantle cell lymphoma"],"catalyst":""},{"name":"saquinavir/ritonavir","genericName":"saquinavir/ritonavir","slug":"saquinavir-ritonavir","phase":"marketed","mechanism":"Saquinavir and ritonavir are protease inhibitors that block HIV protease, preventing viral replication by inhibiting the cleavage of viral polyproteins.","indications":["HIV-1 infection in treatment-experienced patients","HIV-1 infection in antiretroviral-naive patients"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE5OZWFER3ZlcTVqNVVuWmJFclpUYlNuY1pUaEdTUGpLN2lrLTRKSnNNUWllV0tUejItaE1ibno1eldNZlM1bWRMM0VuaWFfME1WV2MxeFFhdVdSZURqeWxxbTJ3?oc=5","date":"2026-04-02","type":"pipeline","source":"CIOReview","summary":"Medimix International: Ushering in Real World Evidence Insights for Driving Success - CIOReview","headline":"Medimix International: Ushering in Real World Evidence Insights for Driving Success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPNjV6MmVWd1lzWElqUWZGUFRlTjNuelBUTHRMUnAtc1ZXY2dCT3NlZXVPQlRoRk9XLWZNNVV0cmE4SGQ4RTE2S2Zjb2JnZDF4U0dydk9QZW1IaVJjeHJiTjFNRXAxUG91aE9wSnBsOGlvRkhlZFlJbEp4czhJTEZxSHQ0TGktcEdQN25QRE5TRDgzVTFCbUdRaDdHdllINmt2a2RXQVRkbjNHRldqT01DallKZENaOEZxWlFZRlNrOWRsTkIxRFZMUk9hZw?oc=5","date":"2026-04-01","type":"pipeline","source":"Stock Titan","summary":"Ascentage Pharma (AAPG) shifts principal Hong Kong business address - Stock Titan","headline":"Ascentage Pharma (AAPG) shifts principal Hong Kong business address","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOMGs5Rm9yR09GcDBZZk44UFVacWxFalNyREZma01vbG9hOGlJbzRIOHhTcFBRWlVlSFp1OFJ0RURualZSMVM0a281c2VzcTNpaXhYWVRIMTJHajJqRjl1RWtsNlo4Yy1rUlBIcFlkb3BvUS1PVEUzS25HR3BMdE0xQ1JYc2pFSTRGS3lfQUpINjl6UFJsNElTWGdOeDdoamVUSGcwYXFLMEJhTzhjZmphTEQtcFYwZw?oc=5","date":"2026-02-19","type":"pipeline","source":"Statista","summary":"Global pharma market in-house vs outsourced services expenditure share 2014-2023 - Statista","headline":"Global pharma market in-house vs outsourced services expenditure share 2014-2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOeGJlU0dfWlJTanBnUTBEV0lSNE9hc3RxQ2dkdzJBcjNfNEJhWFBYMTFsaGxMdF9MZGRZWUpSOUFfblp5ZGlGZnBJT3JhNGpCclJ2THJySEstckt5NWNkejN0Nk1pdTZUVTNCeDV0bjlxVlJiMXNCdDMyTkxDOHZtN3cwQjlvc2drOW1EMUU0X0dWZnVLUmlCV3hYMVB2NTgxQm9SN2VuaV82RGhHZWNLMlM5MkNvSnF2dEVybUZEYlU?oc=5","date":"2026-02-19","type":"pipeline","source":"Contract Pharma","summary":"VivaMed, Syngene Collaborate on AI-Powered Validation Infrastructure Expansion - Contract Pharma","headline":"VivaMed, Syngene Collaborate on AI-Powered Validation Infrastructure Expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOOWhpaXotUHVZZnBQYzVLRFoxYkRPQU9sMW96Z241dDlOY3N4bEo5Rlg4YmotOTZQbHpZSzNBYUlrZXpUOWxKaDFwMmV3ZGRPU3FQUjFOdFdfSEctVVNXaW85cDdTcEtITUFEdmhnNGpESlNHVjJSa1ZQdXdZSFlYRXI3WUxjN0VO?oc=5","date":"2025-12-26","type":"pipeline","source":"Yahoo Finance","summary":"This International Pharma Stock Just Hit 5-Year Highs - Yahoo Finance","headline":"This International Pharma Stock Just Hit 5-Year Highs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxORko1bVJTb3RXcWd5QXBpQ012dUo4TVhIbVNpYTdxOHdUMnRKVHB4Vk1jMU9WQk1JVU90Ry1weU9tdjNCMzNaTUJvZFdsRENVR2JoT1FOUGprcmNUc2NPTy16MXpvMHZkYUI2LUY2elhtOUU5dW05eEJrMWZaQUU1TG1GZWdjXzI4b3hSSmp0RDJsZkk?oc=5","date":"2025-11-05","type":"pipeline","source":"Maersk","summary":"Discover supply chain innovation at Pharma Asia International Conference 2025 - Maersk","headline":"Discover supply chain innovation at Pharma Asia International Conference 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxObDVNcUVGNDVqRk9iZjFZUlUyeGp2ZFprLVFJWldJWEdqNUo5T0FLeG5XWWhrYkJIMDRxdkN1QVV0MUxxWnViR2hvRzROMmUyVjFLSkJZdGZxeWMxZTlVSWZLbl9tWVlRUmJJOS1Yanp4VHJ5VVppLW9xeHZBUS0wYWh5cHlCZDVEYzJJRFdDR2ptSTBMVExjOU1VeE9saU9PWHZ6c2EzMG0tOGhrZ0pkWWxRQ0hWZ3ZtNEl2MVR5UTZPeXUzODlCZFNNWmtfOHF3d2plWkFYUkVGU0p1RVJkbkFQUUREUQ?oc=5","date":"2025-10-21","type":"pipeline","source":"Pharmacy Practice News","summary":"Fosun Pharma/MAP International Collaborate to Deliver Pain Relief Medication - Pharmacy Practice News","headline":"Fosun Pharma/MAP International Collaborate to Deliver Pain Relief Medication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxQcjlWbGN4UWNTN1Nfb1d3eVc5NVlVV216R3M2UlN5TUhrdm1vTWluV1hzVFFuM2FBdHBuOXFEV2l5YWhsTkZmcEpabnVVM0lKX096cTBwNkxrdTB3V0lLOXdwZVRvMGc0YnFCbTFDd2tNd3JHZURLeFNBREQ0SnM5aEhoR2J0U3VzWC1od2FwcHMxVnIxMWhsVF9rc1BCR0hLVC1NRm54U05nU05lQlU0V1FDUUhYRm5mX252SE9NSDB4ZWVfZS03UUNxaTFJZlNGNG5SQ29KWmt5aW1hd1l3S2ExNW9FUWR3bHhCdWY0bUJEdWIyc1JwdDFIVGRhR1RBX2JUejdDcjFSTGlaeHRINUlQUmxzSUdmOExzTFFDd2VDUGs?oc=5","date":"2025-09-16","type":"deal","source":"GlobeNewswire","summary":"Close-Up International Acquires Pharma CRM Provider - GlobeNewswire","headline":"Close-Up International Acquires Pharma CRM Provider","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQVnpmUTh5bGRMSjlEX0J1c3d3SnJIczZTVm1XZ1lEYlExQ0Fycjl4cmpQdEdVdWpRWjk2MHBRV1JuLWp4Y0x6eldNQ3liNmNQOHBwZVVQS2VzNFhHQ2VVVDFrMS1OdjRYaHlyNk1ma3FackFOZzlncE9XNm02RVFlaGVUYUhrd3l3V2prdFhnaWxJMjhra0dXU1Vua1VKY1lIemJma1g2RHdITTg?oc=5","date":"2025-08-29","type":"regulatory","source":"BioPharm International","summary":"New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s - BioPharm International","headline":"New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQUlp3Qk84T05UeHd3UjRZQW44ellYQ3RiYkgwMmg1d1JsQm1uQU1hOXNvUWpUMXIyUkFYY1p3cEVfM0FhV0JYS0s3NmxfVmpjdnIyRkpCSEhXRTZXLXFwYmhiRi1VWFdCcFVFNkwyYWFpc015dWFFYkVtUS1hcGstX005ZXJKRE1kcTB6XzVoTXR0VnFVRUo4dkN1QlFUcHd3dHMyTktGTm1IQk9lMUFsUk5KbW1CWnNYQ0I3Y2toTFhmelE?oc=5","date":"2025-08-07","type":"pipeline","source":"Fierce Pharma","summary":"Amid MFN talks, Lilly chief warns US adoption of international drug prices could bring 'worst of two worlds' - Fierce Pharma","headline":"Amid MFN talks, Lilly chief warns US adoption of international drug prices could bring 'worst of two worlds'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbzktb0ZpdUxHb0NIMGN5SjFBWG4zTjRCNmdqbHh4ZndyMjRfNHR6Yk1HNXpBVF93d1BlbzBNNGJfSXNNbnh4cGlxbFFiRmpwMmV4Vkd3WHJycDhfM1ZEZE1PcGVBb1htTVM0OW56cFBlZmVXV3FnZjdWcWtqZXV6aEY4RTFqODFNbUFfNVlOeW9kUm5BQUVhXzhudktUOWcxdUdWVlZtLVA?oc=5","date":"2025-08-06","type":"pipeline","source":"BioSpace","summary":"Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive - BioSpace","headline":"Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNdUtOMFVhU0N0VUk1NlU4Vzcyd0o5a2czbTFYMUZDR0xNU01FaE9XZVRFLVdUUXlFSlFwZ0lERFZQckYwU0daUkFzTlhqU0lQSDFWMzNEU2hjRXl4cGEzVWdXbmNTck1KaG5WWTJrVDkxcVBLaUlXdUN4c3BpeEhiLXI0UWtzN2pTcEJZd3J3TG9NNnZkUkFDNDhQTkx2WnhwVWN4Mmx3?oc=5","date":"2025-06-24","type":"pipeline","source":"北京市人民政府外事办公室","summary":"Yin Li Meets with Heads of Multinational Pharma Companies Attending IPIF 2025_Headlines - 北京市人民政府外事办公室","headline":"Yin Li Meets with Heads of Multinational Pharma Companies Attending IPIF 2025_Headlines - 北京市人民政府外事办公室","sentiment":"neutral"},{"date":"2012-10-18","type":"earnings","source":"SEC EDGAR","summary":"SC 13G filed with SEC: SC 13G","headline":"SC 13G Filing","sentiment":"neutral"},{"date":"2012-08-20","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: QUARTERLY REPORT","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2012-07-18","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"}],"patents":[],"drugCount":64,"phaseCounts":{"marketed":37,"phase_1":7,"phase_3":19,"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":310614,"revenuePeriod":"2011-12-31","revenueHistory":[{"value":310614,"period":"2011-12-31"},{"value":148122,"period":"2010-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-3451195,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":1785209,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}